The medical community has long sought a cost-effective, reliable, non-invasive method to improve the detection of endothelial dysfunction, in order to screen larger segments of the population safely and reliably, and to enhance follow-up for sufferers of cardiac disease. Itamar Medical's Endo-PAT2000 is meeting this challenge, and is ideally suited to enhance the traditional clinical settings’ diagnostic capabilities. The Endo-PAT2000 can be used in any setting, from hospital bedside to outpatient clinic.
Endo-PAT2000 is the leading medical device for noninvasive endothelial function assessment. It is FDA-cleared, CE-marked and used in preeminent clinical institutions, research centers and Pharmaceutical clinical phase studies in over 40 countries. It is incorporated into numerous multi-center and population-based studies such as the Framingham Heart Study. Research using Endo-PAT has yielded more than 100 articles in peer-reviewed journals and abstracts. It is becoming widely recognized as the standard method for endothelial function assessment. Some of the features that make Endo-PAT appealing are its ease of use, user-independence and immediate, automatically calculated test results. It provides clinicians with a reliable and reproducible index of endothelial function in a 15-minute, office-based test.
Endo-PAT2000
Non-invasive assessment of endothelial function
Watch-PAT200
Ambulatory diagnosis of sleep related breathing disorders
Endo-PAT2000
EndoPAT Product Overview
EndoPAT on Today Show
